Double robust estimation of optimal partially adaptive treatment strategies: An application to breast cancer

Denis Talbot1,2, Erica E M Moodie3, Caroline Diorio1,4

  • 1Département de médecine sociale et préventive, Université Laval, Québec, Canada.

Statistics in Medicine
|November 21, 2022
PubMed

Insights

This study introduces new methods for precision medicine, enabling tailored cancer treatments using partially adaptive strategies. These approaches improve upon existing techniques by simplifying treatment decisions for better patient outcomes.

Area of Science:

  • Biostatistics
  • Computational Biology
  • Precision Medicine

Background:

  • Precision medicine seeks to personalize patient treatment based on individual characteristics.
  • Existing double robust methods like G-estimation and dynamic weighted ordinary least squares (dWOLS) for optimal adaptive treatment strategies require modeling all treatment-confounder interactions.
  • This complexity can be impractical for real-world applications.

Purpose of the Study:

  • To develop and evaluate novel estimators for partially adaptive treatment strategies.
  • To demonstrate the double robustness of these new estimators.
  • To apply these methods to identify optimal hormonal therapy strategies for breast cancer patients.

Main Methods:

  • Building upon G-estimation and dWOLS, new estimators for partially adaptive strategies were developed.
  • The double robustness of the proposed estimators was theoretically demonstrated.
  • A simulation study was conducted to investigate the performance of the estimators.
  • The methods were applied to real-world breast cancer patient data from the Centre des Maladies du Sein.

Main Results:

  • The proposed estimators were shown to be double robust.
  • The simulation study validated the performance of the new methods.
  • A partially adaptive treatment strategy for hormonal therapy in breast cancer was estimated using real patient data.

Conclusions:

  • Partially adaptive treatment strategies, which tailor treatments based on a subset of covariates, are valuable in precision medicine.
  • The developed estimators offer a more practical approach to identifying optimal treatment strategies compared to existing methods.
  • The findings provide a new tool for tailoring breast cancer hormonal therapy.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
415
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
248
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
157
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K